SiliconInvestor
     Advanced Search   [ sign in ]

sponsor
Sponsor

 Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Brian Malloy who wrote (135)12/1/1999 3:00:00 AM
From: glenRead Replies (1) of 250
 
Welcome to VaxGen. Your investment objectives are exactly as they should be. The wait should be closer to two years, rather than three, and the FDA can move faster if the results of Phase 3 Trials are favorable. If VaxGen does succeed in obtaining FDA approval, this could be a $200 stock. Their potential target market will be the world's population. This is a company with little hype, and very much under-rated and misunderstood. They have a much better chance of succeeding than most realize.

Regards,
glen
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.